{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:12:40Z","timestamp":1792177960041,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1353,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["G0801176"],"award-info":[{"award-number":["G0801176"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000277","name":"UK Department for Environment, Food and Rural Affairs","doi-asserted-by":"crossref","award":["SEV3500"],"award-info":[{"award-number":["SEV3500"]}],"id":[{"id":"10.13039\/501100000277","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000686","name":"the Royal College of Veterinary Surgeons Trust","doi-asserted-by":"crossref","award":["GR000 683"],"award-info":[{"award-number":["GR000 683"]}],"id":[{"id":"10.13039\/501100000686","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.024","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T09:08:56Z","timestamp":1258535336000},"page":"7178-7186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa"],"prefix":"10.1016","volume":"27","author":[{"given":"Edward","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"McNabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudy","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H.","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cleaveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Fooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.vaccine.2009.09.024_bib1","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/j.vaccine.2005.10.015","article-title":"Preventing the incurable: Asian rabies experts advocate rabies control","volume":"24","author":"Dodet","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.024_bib2","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.09.024_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-8-113","article-title":"Rabies trend in China (1990\u20132007) and post-exposure prophylaxis in the Guangdong province","volume":"8","author":"Si","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.024_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2460\/javma.231.4.540","article-title":"Rabies surveillance in the United States during 2006","volume":"231","author":"Blanton","year":"2007","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.024_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14760584.3.4.333","article-title":"The challenge of new and emerging lyssaviruses","volume":"3","author":"Fooks","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.024_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3201\/eid0903.020252","article-title":"New lyssavirus genotype from the Lesser mouse-eared bat (Myotis blythi), Kyrghyzstan","volume":"9","author":"Arai","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.024_bib7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3201\/eid0912.030374","article-title":"Novel lyssaviruses isolated from bats in Russia","volume":"9","author":"Botvinkin","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.024_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-1702(03)00217-X","article-title":"Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences","volume":"97","author":"Kuzmin","year":"2003","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.024_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2008.02.001","article-title":"Phylogeny of Lagos bat virus: challenges for lyssavirus taxonomy","volume":"135","author":"Markotter","year":"2008","journal-title":"Virus Res"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.024_bib10","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3201\/eid1412.080671","article-title":"New rabies virus variant in Mexican immigrant","volume":"14","author":"Velasco-Villa","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.024_bib11","first-page":"161","article-title":"Emergence of lyssaviruses in the Old World: the case of Africa","volume":"315","author":"Nel","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.024_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3201\/eid1406.071421","article-title":"Antibodies against Lagos bat virus in megachiroptera from West Africa","volume":"14","author":"Hayman","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.024_bib13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/JCM.00016-08","article-title":"Lagos bat virus in Kenya","volume":"46","author":"Kuzmin","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2009.09.024_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0035-9203(98)90718-0","article-title":"Epidemiology and control of rabies. The growing problem of rabies in Africa","volume":"92","author":"Cleaveland","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.024_bib15","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1371\/journal.pntd.0000339","article-title":"Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies","volume":"2","author":"Hampson","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2009.09.024_bib16","series-title":"Rabid Bytes","article-title":"The 9th SEARG meeting in Gaborone, Botswana","author":"Hampson","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.024_bib17","unstructured":"Anonymous. WHO Expert Consultation on Rabies. WHO Technical Report Series; 2005. p. 931."},{"key":"10.1016\/j.vaccine.2009.09.024_bib18","unstructured":"Dodet B, Fooks AR, Muller T, Tordo N (eds). Towards the Elimination of Rabies in Eurasia. OIE Publications; 2008."},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.024_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.024_bib20","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.024_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2003.12.001","article-title":"Development of a qualitative indirect ELISA for the measurement of rabies virus-specific antibodies from vaccinated dogs and cats","volume":"117","author":"Cliquet","year":"2004","journal-title":"J Virol Methods"},{"issue":"32","key":"10.1016\/j.vaccine.2009.09.024_bib22","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses","volume":"23","author":"Brookes","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.024_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jviromet.2004.12.003","article-title":"A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein","volume":"125","author":"Khawplod","year":"2005","journal-title":"J Virol Methods"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2009.09.024_bib24","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","article-title":"Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison","volume":"89","author":"Wright","year":"2008","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.024_bib25","first-page":"379","article-title":"Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system","volume":"7","author":"DuBridge","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2009.09.024_bib26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/2031355a0","article-title":"Syrian hamster fibroblast cell line BHK21 and its derivatives","volume":"203","author":"Stoker","year":"1964","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.024_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1999.0633","article-title":"Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line","volume":"258","author":"Soda","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.024_bib28","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/jvi.64.5.2416-2420.1990","article-title":"Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants","volume":"64","author":"Helseth","year":"1990","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2009.09.024_bib29","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.024_bib30","first-page":"357","article-title":"TreeView: an application to display phylogenetic trees on personal computers","volume":"12","author":"Page","year":"1996","journal-title":"Comput Appl Biosci"},{"issue":"19","key":"10.1016\/j.vaccine.2009.09.024_bib31","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.1073\/pnas.88.19.8377","article-title":"Retroviral-mediated gene transfer into hepatocytes in vivo","volume":"88","author":"Ferry","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.024_bib32","first-page":"103","article-title":"Control and prevention of rabies in animals: paradigm shifts","volume":"125","author":"Rupprecht","year":"2006","journal-title":"Dev Biol (Basel)"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.024_bib33","first-page":"1389","article-title":"The rabies epidemic on Flores Island, Indonesia (1998\u20132003)","volume":"87","author":"Windiyaningsih","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.vaccine.2009.09.024_bib34","first-page":"213","article-title":"The Pan American Health Organization (PAHO) role in the control of rabies in Latin America","volume":"119","author":"Belotto","year":"2004","journal-title":"Dev Biol (Basel)"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2009.09.024_bib35","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0264-410X(02)00778-8","article-title":"A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries","volume":"21","author":"Cleaveland","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.024_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vaccine.2008.09.054","article-title":"Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination","volume":"27","author":"Kaare","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.024_bib37","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.024_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3201\/eid1103.040906","article-title":"Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes","volume":"11","author":"Temperton","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.024_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1750-2659.2007.00016.x","article-title":"A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies","volume":"1","author":"Temperton","year":"2007","journal-title":"Influenza Resp Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.024_bib40","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","article-title":"Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines","volume":"72","author":"Wool-Lewis","year":"1998","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:16:22Z","timestamp":1759400182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":40,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013486"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}